Assistant Professor, Pediatrics School of Medicine
Contact
Zoe King, D.O., is a pediatric oncologist at Maria Fareri Children’s Hospital. While completing a fellowship in pediatric hematology/oncology at the Children’s Hospital at Montefiore, she worked in the Shastri Lab doing research on BAX-mediated cell death as a therapeutic strategy in drug-resistant and aggressive myeloid neoplasms. She is published in the field of clonal hematopoiesis and STAT signal pathways leading to acute myeloid malignancy. Currently, her clinical and research focus is on children with cancer predisposition syndromes.
Education
- Fellowship, Pediatric Hematology/Oncology, Children's Hospital at Montefiore/Albert Einstein College of Medicine
- Residency, Pediatrics, Nemours Children's Hospital/Thomas Jefferson University School of Medicine
- D.O., Philadelphia College of Osteopathic Medicine
- M.S., Biological Sciences, Drexel University
- B.S., Biology, American University
Areas of Expertise
- Childhood Cancer Predisposition Syndrome
- Acute Myeloid Leukemia
- Acute Lymphoid Leukemia
Publications
- King Z, Anosike BI, Offenbacher R, et. al. "A 7-Year-Old Boy with Prolonged Fever." NEJM evidence, 4(5), (2025) EVIDmr2400330. doi: 10.1056/EVIDmr2400330
- King Z, Desai SR, Frank DA, et. al. "STAT signaling in the pathogenesis and therapy of acute myeloid leukemia and myelodysplastic syndromes." Neoplasia (New York, N.Y.), 61(), (2025) 101137. doi: 10.1016/j.neo.2025.101137
- Haque T, Shastri A, Desai P, et. al. "A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis." British journal of haematology, 206(2), (2025) 416-427. doi: 10.1111/bjh.19925
- King Z, Mitchell WB. "Learning curve: machine learning takes on pediatric hematologic malignancy risk-stratification." Pediatric research, 97(2), (2025) 480-481. doi: 10.1038/s41390-024-03661-y
- King Z, Brown-Johnson C, Forneret A, et. al. "Promoting Diversity, Equity, Inclusion, and Justice in Grantmaking for Health Care Research: A Pragmatic Review and Framework." Health equity, 8(1), (2024) 391-405. doi: 10.1089/heq.2023.0263
- King Z, Fraint E. "Chimeric Antigen Receptor T-Cell Treatment in Children." Pediatrics in review, 45(5), (2024) 301-302. doi: 10.1542/pir.2023-006126
- Demirhan S, King Z, Sohail SS, et. al. "Human Adenovirus B3 Associated Colitis and Hemophagocytic Lymphohistiocytosis in 9-Year-old Previously Healthy Girl." The Pediatric infectious disease journal, 43(7), (2024) e257-e259. doi: 10.1097/INF.0000000000004328
